Orio Therapeutics ^None

Orio Therapeutics is a company that aims to develop regenerative drugs with increased efficacy and reduced side-effects. They use targeted drug-delivery technologies to create novel therapeutic proteins and aim to validate their program pipeline through the development of a therapeutic molecule for myocardial infarction. Their goal is to make regenerative medicine accessible and a widespread reality.